SeekingAlpha · Oct 26, 2026
How Can Investors Have Confidence In The Terminal Value Of The Large AI Providers
Greenlight Capital questions the market valuations and TAM claims of AI providers in Q3 2026. Read the full analysis for more details.
AC
NASDAQ · ACHC
Acadia Healthcare Company, Inc.
Healthcare · Medical - Care Facilities
$29.96
Up+$0.50 (+1.70%)
Updated Oct 31, 2026, 7:07 PM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.12B
- P/E ratio
- -1.92
- Dividend yield
- 0.00%
- 52-week range
- $11.43 – $35.83
- Volume
- 2.58M
- Avg. volume
- 3.8M
Price performance · ACHC
ACHC price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
ACHC closed at $29.96 after 21 trading sessions, up 6.77% for the selected period.
- Last close
- $29.96
- Period change
- +6.77%
- Period low
- $28.06
- Period high
- $31.88
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $29.30 | $30.02 | $29.02 | $29.96 | 2.58M |
| Oct 29, 2026 | $29.84 | $30.095 | $28.89 | $29.46 | 2.74M |
| Oct 28, 2026 | $29.65 | $30.52 | $29.29 | $29.51 | 2.19M |
| Oct 27, 2026 | $31.51 | $31.61 | $29.35 | $29.90 | 2.34M |
| Oct 26, 2026 | $31.71 | $32.405 | $31.0634 | $31.34 | 1.37M |
| Oct 23, 2026 | $31.61 | $32.36 | $31.41 | $31.51 | 1.48M |
| Oct 22, 2026 | $31.51 | $32.1999 | $31.05 | $31.88 | 1.26M |
| Oct 21, 2026 | $31.58 | $32.09 | $30.53 | $31.43 | 1.12M |
| Oct 20, 2026 | $30.25 | $31.58 | $30.11 | $31.43 | 1.38M |
| Oct 19, 2026 | $30.16 | $30.5099 | $29.73 | $30.18 | 996.21K |
| Oct 16, 2026 | $30.905 | $31.07 | $29.87 | $29.98 | 1.52M |
| Oct 15, 2026 | $31.67 | $32.03 | $30.891 | $31.04 | 1.89M |
| Oct 14, 2026 | $29.84 | $31.895 | $29.84 | $31.67 | 1.93M |
| Oct 13, 2026 | $30.20 | $30.80 | $29.59 | $30.23 | 1.27M |
| Oct 12, 2026 | $29.10 | $30.21 | $29.07 | $30.08 | 1.21M |
| Oct 9, 2026 | $28.31 | $29.45 | $28.31 | $29.25 | 1.38M |
| Oct 8, 2026 | $28.86 | $29.0631 | $28.39 | $28.48 | 1.3M |
| Oct 7, 2026 | $28.84 | $29.655 | $28.66 | $29.23 | 1.65M |
| Oct 6, 2026 | $28.835 | $29.255 | $28.43 | $29.04 | 1.42M |
| Oct 5, 2026 | $28.32 | $28.92 | $27.83 | $28.87 | 2.43M |
| Oct 2, 2026 | $27.27 | $28.32 | $26.76 | $28.06 | 1.44M |
Latest ACHC news
The latest Smart Investors Daily articles mentioning ACHC.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ACHC research
Overview
Company profile and research snapshot.
Company profile
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $19.11
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | Leerink Partners | Market Perform | — |
| Jul 30, 2026 | Guggenheim | Buy | — |
| Jul 30, 2026 | Barclays | Equal-Weight | — |
| Jul 20, 2026 | Guggenheim | Buy | — |
| Jul 14, 2026 | TD Cowen | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 23, 2026
Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings
IDXX heads into Q3 earnings with expected revenue and EPS growth, fueled by CAG Diagnostics momentum, higher testing volumes and software gains.
Yahoo · Oct 22, 2026
Align Technology to Report Q3 Earnings: What's in the Cards?
ALGN's Q3 earnings may benefit from Clear Aligner growth and digital innovations, while capital equipment market challenges could weigh on results.
Yahoo · Oct 21, 2026
Labcorp Prepares to Report Q3 Earnings: What's in the Cards?
LH's Q3 earnings may benefit from strong diagnostics demand, specialty testing expansion and acquisitions, with revenues projected to grow 5.7%.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
